Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of a Covalent FEM1B Recruiter for Targeted Protein Degradation Applications
Nathaniel J. Henning, Andrew G. Manford, Jessica N. Spradlin, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 2, pp. 701-708
Open Access | Times Cited: 158

Showing 51-75 of 158 citing articles:

Elucidation of E3 ubiquitin ligase specificity through proteome-wide internal degron mapping
Zhiqian Zhang, Brandon Sie, Aiquan Chang, et al.
Molecular Cell (2023) Vol. 83, Iss. 18, pp. 3377-3392.e6
Open Access | Times Cited: 21
Proteome‐Wide Fragment‐Based Ligand and Target Discovery
Ines Forrest, Christopher G. Parker
Israel Journal of Chemistry (2023) Vol. 63, Iss. 3-4
Open Access | Times Cited: 17
N-Acryloylindole-alkyne (NAIA) enables imaging and profiling new ligandable cysteines and oxidized thiols by chemoproteomics
Tin-Yan Koo, Hinyuk Lai, Daniel K. Nomura, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Proteome-wide structural analysis identifies warhead- and coverage-specific biases in cysteine-focused chemoproteomics
Matthew White, Jesús Gil, Edward W. Tate
Cell chemical biology (2023) Vol. 30, Iss. 7, pp. 828-838.e4
Open Access | Times Cited: 17
Revolutionizing Drug Targeting Strategies: Integrating Artificial Intelligence and Structure-Based Methods in PROTAC Development
Mohd Danishuddin, Mohammad Sarwar Jamal, Kyoung Seob Song, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1649-1649
Open Access | Times Cited: 17
Targeted Protein Degradation: Current and Emerging Approaches for E3 Ligase Deconvolution
Yufeng Xiao, Yaxia Yuan, Yi Liu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 8
Breaking Bad Proteins—Discovery Approaches and the Road to Clinic for Degraders
Corentin Bouvier, Rachel Lawrence, Francesca Cavallo, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 578-578
Open Access | Times Cited: 7
Delineating cysteine-reactive compound modulation of cellular proteostasis processes
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 7
Structural insights into the ubiquitylation strategy of the oligomeric CRL2FEM1B E3 ubiquitin ligase
Zonglin Dai, Ling Liang, Weize Wang, et al.
The EMBO Journal (2024) Vol. 43, Iss. 6, pp. 1089-1109
Open Access | Times Cited: 6
Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation
Dhanusha A. Nalawansha, Ke Li, John Hines, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 12, pp. 5594-5605
Open Access | Times Cited: 27
Proteome-scale induced proximity screens reveal highly potent protein degraders and stabilizers
Juline Poirson, Akashdeep Dhillon, Hanna Cho, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 25
Progress of small molecules for targeted protein degradation: PROTACs and other technologies
Hongyi Zhao, Minhang Xin, San‐Qi Zhang
Drug Development Research (2023) Vol. 84, Iss. 2, pp. 337-394
Closed Access | Times Cited: 16
A covalent BTK ternary complex compatible with targeted protein degradation
James Schiemer, Andrew Maxwell, Reto Horst, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
A simple method for developing lysine targeted covalent protein reagents
Ronen Gabizon, Barr Tivon, Rambabu Reddi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Enhanced Tumor Targeting and Penetration of Proteolysis-Targeting Chimeras through iRGD Peptide Conjugation: A Strategy for Precise Protein Degradation in Breast Cancer
Shipeng He, Yuxin Fang, Ming‐Hao Wu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 16828-16842
Closed Access | Times Cited: 15
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
Nisha Setia, Haider Thaer Abdulhameed Almuqdadi, Mohammad Abid
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116041-116041
Closed Access | Times Cited: 14
Chemical Proteomics–Guided Discovery of Covalent Ligands for Cancer Proteins
Xiaoyu Zhang, Benjamin F. Cravatt
Annual Review of Cancer Biology (2024) Vol. 8, Iss. 1, pp. 155-175
Open Access | Times Cited: 5
Covalent PROTACs: the best of both worlds?
Neil P. Grimster
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 9, pp. 1452-1458
Open Access | Times Cited: 32
Chemically induced degradation of epigenetic targets
Md Kabir, Xufen Yu, H. Ümit Kanıskan, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 13, pp. 4313-4342
Open Access | Times Cited: 13
A Neutral Polysaccharide from Spores of Ophiocordyceps gracilis Regulates Oxidative Stress via NRF2/FNIP1 Pathway
Yue Wang, Shixiang Wei, Hui Qin Lian, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14721-14721
Open Access | Times Cited: 12
Overview of Class I HDAC Modulators: Inhibitors and Degraders
Ziqian Huang, Limei Zeng, Binbin Cheng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116696-116696
Closed Access | Times Cited: 4
Clozapine as an E3 Ligand for PROTAC Technology
Reina Takano, Nobumichi Ohoka, Takashi Kurohara, et al.
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 2, pp. 258-262
Closed Access
New Insights into Reductive Stress Responses and its Clinical Relation in Cancer
Suman Kumar Ray, Sukhes Mukherjee
Tissue and Cell (2025) Vol. 93, pp. 102736-102736
Closed Access
The recent advance of PROTACs targeting BCR-ABL for the treatment of chronic myeloid leukemia
Zhuo Qian, Yi‐Ru Bai, Wenjuan Zhou, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108189-108189
Closed Access
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access

Scroll to top